1. Home
  2. SLNG vs PMVP Comparison

SLNG vs PMVP Comparison

Compare SLNG & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

N/A

Current Price

$4.60

Market Cap

103.2M

Sector

Utilities

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.32

Market Cap

79.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
PMVP
Founded
2013
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.2M
79.5M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
SLNG
PMVP
Price
$4.60
$1.32
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
71.0K
428.6K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
2400.00
N/A
EPS
N/A
N/A
Revenue
$68,245,000.00
N/A
Revenue This Year
$8.66
N/A
Revenue Next Year
$14.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.21
$0.82
52 Week High
$6.36
$1.88

Technical Indicators

Market Signals
Indicator
SLNG
PMVP
Relative Strength Index (RSI) 48.03 44.12
Support Level $3.25 $1.26
Resistance Level $5.10 $1.50
Average True Range (ATR) 0.49 0.06
MACD 0.10 -0.04
Stochastic Oscillator 65.12 24.36

Price Performance

Historical Comparison
SLNG
PMVP

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: